Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

NEW YORK PRIMARY CARE MEDICINE PC

NPI: 1093815771 · NEW YORK, NY 10033 · Family Medicine Physician · NPI assigned 09/23/2006

$179K
Total Medicaid Paid
109,727
Total Claims
95,866
Beneficiaries
127
Codes Billed
2018-01
First Month
2024-05
Last Month

Provider Details

Authorized OfficialCHABLA, JUAN (PRESIDENT)
NPI Enumeration Date09/23/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 15,281 $64K
2019 18,564 $51K
2020 14,027 $21K
2021 13,077 $13K
2022 17,012 $11K
2023 24,050 $18K
2024 7,716 $1K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,045 4,409 $49K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,359 1,297 $26K
93000 1,107 1,098 $15K
G0444 Annual depression screening, 5 to 15 minutes 936 930 $12K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 649 647 $11K
G0442 Annual alcohol misuse screening, 5 to 15 minutes 926 908 $11K
99497 384 381 $7K
3074F 3,210 2,707 $5K
3078F 2,850 2,437 $4K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 365 325 $4K
G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes 408 389 $4K
99442 183 176 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 87 86 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,189 1,107 $2K
3077F 818 725 $2K
3079F 1,245 1,149 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 398 378 $2K
3080F 700 632 $2K
36415 Collection of venous blood by venipuncture 4,175 4,025 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 132 126 $2K
1170F 1,923 1,613 $2K
1126F 3,777 3,190 $2K
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 6,517 5,377 $1K
82948 2,747 2,474 $1K
3075F 657 609 $945.05
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 189 177 $908.82
G8510 Screening for depression is documented as negative, a follow-up plan is not required 1,324 1,243 $770.11
1159F 4,704 3,847 $764.00
1160F 4,731 3,862 $556.50
3061F 1,979 1,803 $480.00
G0443 Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes 107 107 $441.46
3044F 1,293 1,209 $438.01
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 15 14 $361.44
99401 404 366 $356.49
0521F 646 596 $328.00
1125F 777 730 $249.00
90674 97 97 $178.45
3049F 633 568 $160.00
3050F 420 364 $104.00
A4556 Electrodes, (e.g., apnea monitor), per pair 451 449 $90.00
97803 90 84 $63.42
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 199 198 $42.53
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 47 45 $17.78
81000 772 749 $15.28
H0001 Alcohol and/or drug assessment 944 900 $10.37
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 1,642 1,397 $9.00
94760 2,544 2,088 $2.88
81002 58 56 $2.02
3048F 1,155 1,017 $0.44
3511F 381 373 $0.28
3008F 4,513 3,691 $0.25
M1189 Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed 253 250 $0.20
90732 12 12 $0.04
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 1,410 1,163 $0.01
G9507 Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) 900 761 $0.01
G9622 Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 539 501 $0.01
G9228 Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) 61 61 $0.00
1000F 295 284 $0.00
3351F 64 64 $0.00
4086F 299 268 $0.00
99429 318 281 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 2,533 2,152 $0.00
97802 150 147 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 134 115 $0.00
2001F 4,445 3,652 $0.00
1036F 1,618 1,460 $0.00
2000F 4,747 3,907 $0.00
G8473 Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed 538 450 $0.00
G8950 Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented 622 530 $0.00
3011F 1,386 1,172 $0.00
99000 1,014 971 $0.00
4010F 505 422 $0.00
G9278 Documentation that the patient is not on daily aspirin or anti-platelet regimen 270 222 $0.00
G2197 Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user 135 135 $0.00
G0475 Hiv antigen/antibody, combination assay, screening 207 207 $0.00
1157F 109 108 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 131 131 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 1,208 1,023 $0.00
M1200 Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period 268 244 $0.00
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening 529 461 $0.00
3014F 12 12 $0.00
4000F 19 19 $0.00
81001 27 26 $0.00
4450F 85 73 $0.00
G9275 Documentation that patient is a current non-tobacco user 13 13 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 262 222 $0.00
G8475 Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given 214 176 $0.00
G8599 Aspirin or another antiplatelet therapy not used, reason not given 304 248 $0.00
G9793 Patient is currently on a daily aspirin or other antiplatelet 120 100 $0.00
3017F 105 101 $0.00
S0257 Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) 66 66 $0.00
3512F 67 67 $0.00
G9508 Documentation that the patient is not on a statin medication 148 126 $0.00
99406 13 13 $0.00
0513F 23 20 $0.00
M1207 Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety 46 46 $0.00
G8755 Most recent diastolic blood pressure >= 90 mmhg 56 51 $0.00
1031F 16 16 $0.00
1123F 14 14 $0.00
1158F 251 245 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 516 438 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 1,118 941 $0.00
99072 1,283 1,121 $0.00
G9820 Documentation of a chlamydia screening test with proper follow-up 240 239 $0.00
3016F 1,116 1,010 $0.00
4013F 1,430 1,177 $0.00
G8935 Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 609 515 $0.00
G9796 Patient is currently on a high intensity statin therapy 574 477 $0.00
3725F 1,122 1,027 $0.00
G9665 Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy 182 158 $0.00
G8506 Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 388 338 $0.00
G8731 Pain assessment using a standardized tool is documented as negative, no follow-up plan required 191 161 $0.00
G9744 Patient not eligible due to active diagnosis of hypertension 292 259 $0.00
G8598 Aspirin or another antiplatelet therapy used 814 707 $0.00
3288F 236 207 $0.00
G9797 Patient is not on a high intensity statin therapy 222 195 $0.00
G0270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes 80 74 $0.00
M1055 Aspirin or another antiplatelet therapy used 51 44 $0.00
G8937 Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given 159 128 $0.00
G8482 Influenza immunization administered or previously received 70 70 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 188 171 $0.00
G2010 Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment 164 161 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 35 32 $0.00
80061 Lipid panel 26 25 $0.00
G0468 Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv 35 35 $0.00
G0445 High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes 110 110 $0.00
A4206 Syringe with needle, sterile, 1 cc or less, each 13 13 $0.00